Stuart Emanuel Selected Research

Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)

12/2005

(6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart Emanuel Research Topics

Disease

8	Neoplasms (Cancer) 11/2014 - 09/2004
1	Melanoma (Melanoma, Malignant) 11/2014
1	Carcinoma (Carcinomatosis) 10/2006
1	Retinoblastoma (Glioblastoma, Retinal) 10/2005
1	Neoplasm Metastasis (Metastasis) 09/2004

Drug/Important Bio-Agent (IBA)

5	Phosphotransferases (Kinase)IBA 06/2011 - 09/2004
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2005 - 09/2004
2	Aurora KinasesIBA 10/2006 - 10/2005
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2006 - 10/2005
2	JNJ-7706621IBA 10/2006 - 10/2005
1	benzamideIBA 11/2014
1	BMS-690514IBA 06/2011
1	matrigelIBA 06/2011
1	Aniline CompoundsIBA 12/2005
1	PDGF receptor tyrosine kinaseIBA 12/2005
1	Becaplermin (PDGF-BB)FDA Link 12/2005
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2005
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2005
1	Pharmaceutical PreparationsIBA 10/2005
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 10/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2004
1	4- (4- (1- Amino- 1- methylethyl)phenyl)- 2- (4- (2- morpholin- 4- yl- ethyl)phenylamino)pyrimidine- 5- carbonitrileIBA 09/2004
1	Angiogenesis InhibitorsIBA 09/2004

Therapy/Procedure

1	Aftercare (After-Treatment) 09/2004
1	Therapeutics 09/2004